The alpha glucosidase inhibitors market size is expected to see strong growth in the next few years. It will grow to $6.11 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing emphasis on early intervention, rising geriatric population, global healthcare initiatives for diabetes control, integration into combination therapies.. Major trends in the forecast period include patient-centric approaches, focus on type 2 diabetes management, technological advancements in drug delivery, emerging markets and globalization, collaborations and partnerships..
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/alpha-glucosidase-inhibitors-global-market-report
Segmentation & Regional Insights
The alpha glucosidase inhibitors market covered in this report is segmented –
1) By Type: Dumping Syndrome, Type 2 Diabetes
2) By Drug class: Acarbose, Miglitol, Voglibose
3) By Constituent: Glucoamylase, Isomaltase, Maltase, Sucrase
4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies
North America was the largest region in the alpha glucosidase inhibitors market in 2023. Middle-East is expected to be the fastest-growing region in the forecast period. The regions covered in the alpha glucosidase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11880&type=smp
Major Driver Impacting Market Growth
Rising diabetes prevalence globally is expected to propel the growth of the alpha-glucosidase inhibitors market going forward. Diabetes is a long-term metabolic condition marked by high blood glucose (also known as blood sugar) levels, which can seriously harm the heart, blood vessels, eyes, kidneys, and nerves over time. Alpha-glucosidase inhibitors prevent carbohydrate absorption from the small intestine, which inhibits the rise in postprandial blood glucose concentrations and helps control diabetes. For instance, in November 2022, according to the International Diabetes Federation, a Belgium-based organization for diabetes, globally, 537 million adults (or 1 in 10) had diabetes. Further, the global prevalence of diabetes is expected to increase by 643 million people by 2030 and 783 million people by 2045. Therefore, rising diabetes prevalence globally is driving the growth of the alpha-glucosidase inhibitors market.
Key Industry Players
Major companies operating in the alpha glucosidase inhibitors market report are Pfizer Inc., Roche, Bayer AG, Novartis AG, Sanofi AS, Bristol Myers Squibb Company, AstraZeneca Plc., Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Novo Nordisk AS, Merck KGaA, Sumitomo Chemical Co.Ltd., C. H. Boehringer Sohn AG and Co. KG, Astellas Pharma, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Ltd., Biocon, Torrent Pharmaceuticals, Lotus Pharmaceutical Co. Ltd., Anderson Hay and Grain Co. Inc., BioVision Inc., Border Valley Trading, Straight Healthcare, Synjardi XR
The alpha glucosidase inhibitors market report table of contents includes:
1. Executive Summary
2. Alpha Glucosidase Inhibitors Market Characteristics
3. Alpha Glucosidase Inhibitors Market Trends And Strategies
4. Alpha Glucosidase Inhibitors Market – Macro Economic Scenario
5. Global Alpha Glucosidase Inhibitors Market Size and Growth
………………………..
31. Alpha Glucosidase Inhibitors Market Other Major And Innovative Companies
32. Global Alpha Glucosidase Inhibitors Market Competitive Benchmarking
33. Global Alpha Glucosidase Inhibitors Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Alpha Glucosidase Inhibitors Market
35. Alpha Glucosidase Inhibitors Market Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
https://goodprnews.com/workplace-stress-management-global-market-size/
https://goodprnews.com/breast-cancer-monoclonal-antibodies-global-market-size/
https://goodprnews.com/drugs-for-immunotherapy-global-market-size/
https://topprnews.com/workplace-stress-management-global-market-share/
https://topprnews.com/breast-cancer-monoclonal-antibodies-global-market-share/
https://topprnews.com/drugs-for-immunotherapy-global-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Cosmetic ingredients refer to the substances or components used in the formulation…
Overview and Scope Cosmeceuticals refers to cosmetic products that contain active ingredients with potential therapeutic…
Overview and Scope Xerostomia therapeutics refer to treatments and medications used to manage dry mouth,…
Overview and Scope Dips and spreads are condiments that are produced by combining a range…
Overview and Scope Workstation software is an application designed to enhance productivity and efficiency in…
Overview and Scope Workflow management software refers to a digital tool designed to streamline and…